Renaissance Technologies - AQUESTIVE THERAPEUTICS INC ownership

AQUESTIVE THERAPEUTICS INC's ticker is AQST and the CUSIP is 03843E104. A total of 58 filers reported holding AQUESTIVE THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.33 and the average weighting 1.7%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of AQUESTIVE THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$1,290,120
+21911.9%
496,200
-63.9%
0.00%
-77.8%
Q1 2024$5,861
+128.2%
1,375,800
+8.2%
0.01%
+125.0%
Q4 2023$2,568
+48.6%
1,271,500
+12.6%
0.00%
+33.3%
Q3 2023$1,728
-14.9%
1,129,189
-8.2%
0.00%0.0%
Q2 2023$2,030
+243.5%
1,230,196
+137.1%
0.00%
+200.0%
Q1 2023$591
+41.7%
518,800
+12.1%
0.00%0.0%
Q4 2022$417
-100.0%
462,737
-48.6%
0.00%0.0%
Q3 2022$1,054,000
+34.3%
900,800
-26.5%
0.00%0.0%
Q2 2022$785,000
+772.2%
1,226,400
+3475.5%
0.00%
Q1 2022$90,000
+104.5%
34,300
+204.7%
0.00%
Q4 2021$44,000
-94.7%
11,257
-94.1%
0.00%
-100.0%
Q3 2021$827,000
-15.1%
189,669
-22.7%
0.00%0.0%
Q2 2021$974,000
-33.0%
245,448
-9.7%
0.00%
-50.0%
Q4 2020$1,454,000
+125.8%
271,800
-7.6%
0.00%
+100.0%
Q1 2020$644,000
+40.0%
294,051
+272.2%
0.00%
Q4 2019$460,00079,0000.00%
Other shareholders
AQUESTIVE THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Bratton Capital Management, L.P. 9,810,958$42,776,000100.00%
Latash Investments, LLC 243,134$1,060,0000.66%
Bracebridge Capital, LLC 428,571$1,869,0000.16%
GSA CAPITAL PARTNERS LLP 297,229$1,296,0000.13%
PDT Partners, LLC 76,100$332,0000.02%
Jump Financial, LLC 49,700$216,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 183,000$798,0000.02%
IndexIQ Advisors LLC 86,461$377,0000.01%
Financial Advocates Investment Management 17,000$74,0000.01%
Brandywine Global Investment Management, LLC 125,016$545,0000.00%
View complete list of AQUESTIVE THERAPEUTICS INC shareholders